Cargando…
1211 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Invasive Aspergillosis Patients
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781392/ http://dx.doi.org/10.1093/ofid/ofu051.99 |
| _version_ | 1783294944996229120 |
|---|---|
| author | Kontoyiannis, Dimitrios Giladi, Michael Lee, Misun Nucci, Marcio Raad, Issam Bow, Eric Morrison, Vicki a. Baddley, John Zeiher, Bernhardt Maher, Rochelle Huang, Wenmei Marr, Kieren a. |
| author_facet | Kontoyiannis, Dimitrios Giladi, Michael Lee, Misun Nucci, Marcio Raad, Issam Bow, Eric Morrison, Vicki a. Baddley, John Zeiher, Bernhardt Maher, Rochelle Huang, Wenmei Marr, Kieren a. |
| author_sort | Kontoyiannis, Dimitrios |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5781392 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57813922018-03-01 1211 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Invasive Aspergillosis Patients Kontoyiannis, Dimitrios Giladi, Michael Lee, Misun Nucci, Marcio Raad, Issam Bow, Eric Morrison, Vicki a. Baddley, John Zeiher, Bernhardt Maher, Rochelle Huang, Wenmei Marr, Kieren a. Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781392/ http://dx.doi.org/10.1093/ofid/ofu051.99 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America |
| spellingShingle | IDWeek 2014 Abstracts Kontoyiannis, Dimitrios Giladi, Michael Lee, Misun Nucci, Marcio Raad, Issam Bow, Eric Morrison, Vicki a. Baddley, John Zeiher, Bernhardt Maher, Rochelle Huang, Wenmei Marr, Kieren a. 1211 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Invasive Aspergillosis Patients |
| title | 1211 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Invasive Aspergillosis Patients |
| title_full | 1211 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Invasive Aspergillosis Patients |
| title_fullStr | 1211 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Invasive Aspergillosis Patients |
| title_full_unstemmed | 1211 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Invasive Aspergillosis Patients |
| title_short | 1211 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Invasive Aspergillosis Patients |
| title_sort | 1211 a phase 3, randomized, double-blind, non-inferiority trial to evaluate efficacy and safety of isavuconazole versus voriconazole in patients with invasive mold disease (secure): outcomes in invasive aspergillosis patients |
| topic | IDWeek 2014 Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781392/ http://dx.doi.org/10.1093/ofid/ofu051.99 |
| work_keys_str_mv | AT kontoyiannisdimitrios 1211aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazoleversusvoriconazoleinpatientswithinvasivemolddiseasesecureoutcomesininvasiveaspergillosispatients AT giladimichael 1211aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazoleversusvoriconazoleinpatientswithinvasivemolddiseasesecureoutcomesininvasiveaspergillosispatients AT leemisun 1211aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazoleversusvoriconazoleinpatientswithinvasivemolddiseasesecureoutcomesininvasiveaspergillosispatients AT nuccimarcio 1211aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazoleversusvoriconazoleinpatientswithinvasivemolddiseasesecureoutcomesininvasiveaspergillosispatients AT raadissam 1211aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazoleversusvoriconazoleinpatientswithinvasivemolddiseasesecureoutcomesininvasiveaspergillosispatients AT boweric 1211aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazoleversusvoriconazoleinpatientswithinvasivemolddiseasesecureoutcomesininvasiveaspergillosispatients AT morrisonvickia 1211aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazoleversusvoriconazoleinpatientswithinvasivemolddiseasesecureoutcomesininvasiveaspergillosispatients AT baddleyjohn 1211aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazoleversusvoriconazoleinpatientswithinvasivemolddiseasesecureoutcomesininvasiveaspergillosispatients AT zeiherbernhardt 1211aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazoleversusvoriconazoleinpatientswithinvasivemolddiseasesecureoutcomesininvasiveaspergillosispatients AT maherrochelle 1211aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazoleversusvoriconazoleinpatientswithinvasivemolddiseasesecureoutcomesininvasiveaspergillosispatients AT huangwenmei 1211aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazoleversusvoriconazoleinpatientswithinvasivemolddiseasesecureoutcomesininvasiveaspergillosispatients AT marrkierena 1211aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazoleversusvoriconazoleinpatientswithinvasivemolddiseasesecureoutcomesininvasiveaspergillosispatients |